Skip to the page

Data / Form D filings / Heligenics, Inc.

Heligenics, Inc.: Form D filings

Heligenics, Inc., a biotechnology company in Las Vegas, NV, filed 3 Form D notices with the SEC between 2020 and 2025. The latest, on January 8, 2025, reports $2.6 million sold of a $2.6 million offering to 8 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
10530 DISCOVERY DR, Las Vegas, NV, 89135
Phone
(209) 480-5774
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Nevada
Revenue range
$1 - $1,000,000
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1833506

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 8, 2025New notice$2,631,775$2,631,7758Aug 23, 2024sec.gov
Aug 23, 2022New notice$2,160,000$2,160,00012Jun 9, 2022sec.gov
Dec 16, 2020New notice$2,400,000$1,180,000$1,220,00039Mar 31, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Martin SchillerExecutive Officer

Other biotechnology companies in Nevada that filed recently

Every Form D from the week of Jan 6, 2025 · All recent filings in Nevada · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Heligenics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.